Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$24.46 USD
-0.40 (-1.61%)
Updated May 10, 2024 04:00 PM ET
After-Market: $24.50 +0.04 (0.16%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-1.31 | -3.75% |
Earnings Summary
For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.06 per share, beating the Zacks Consensus Estimate of $-1.35 per share. This reflects a positive earnings surprise of 21.48%. Look out for NTLA's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.31 per share, reflecting a year-over-year increase of 6.43%.
Earnings History
Price & Consensus
Zacks News for NTLA
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
NTLA: What are Zacks experts saying now?
Zacks Private Portfolio Services